Urinary transforming growth factor-β1 and α1-microglobulin in children and adolescents with type 1 diabetes

被引:37
作者
Korpinen, E
Teppo, AM
Hukkanen, L
Åkerblom, HK
Grönhagen-Riska, C
Vaarala, O
机构
[1] Univ Helsinki, Hosp Children & Adolescents, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, Dept Med, Div Nephrol, FIN-00029 Helsinki, Finland
[3] Natl Publ Hlth Inst, Dept Biochem, Helsinki, Finland
关键词
D O I
10.2337/diacare.23.5.664
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- Transforming growth factor (TGF)-beta 1 is an important mediator in the pathogenesis of diabetic nephropathy. Urinary TGF-beta 1 reflects TGF-beta 1 production in the kidney, and alpha 1-microglobulin tubular dysfunction. These 2 markers were studied in the early phases of type 1 diabetes. RESEARCH DESIGN AND METHODS - There were 113 type 1 diabetic children and adolescents (mean +/- SD: age 14.1 +/- 2.9 years, and diabetes duration 7.4 +/- 2.9 years, HbA(1c) 9.3 +/- 1.5%) and 39 healthy subjects (age 13.8 +/- 2.8 years) who participated in the study. Of the diabetic patients, 105 were normoalbuminuric (2-3 consecutive overnight urinary albumin excretion rates [AERs] <20 mu g/min) and 8 had microalbuminuria (at least 2 AERs 20-200 mu g/min). Overnight urinary TGF-beta 1 and alpha 1-microglobulin levels were measured and the results expressed as the ratio to urinary creatinine concentration. RESULTS - Data are medians (range). Diabetic patients had higher urinary TGF-beta 1 levels than those of control subjects: 0.9 ng/mg (0.05-122.3) vs. 0.3 ng/mg (0.05-2.2) creatinine, respectively (P = 0.003). Urinary TGF-beta 1 levels correlated with urinary glucose (r = 0.2, P = 0.03) and alpha 1-microglobulin (r = 0.2, P = 0.02) levels, but not with HbA(1c), AER, age, or duration of diabetes. In 43 patients with urinary TGF-beta 1 above the control levels, urinary TGF-beta 1 levels correlated with urinary glucose (r = 0.6, P ( 0.001) and alpha 1-microglobulin (r = 0.6, P < 0.001) levels. Diabetic patients had higher urinary alpha 1-microglobulin levels than those of control subjects: 4.8 mu g/mg (0.6-48.8) vs. 2.7 mu g/mg (0.8-11.6) creatinine, respectively (P < 0.001). alpha 1-Microglobulin levels correlated with AER (r = 0.2, P = 0.02), HbA(1c) (r = 0.3, P = 0.001), urinary glucose (r = 0.5, P < 0.001), and urinary TGF-beta 1 levels. CONCLUSIONS - An early rise in urinary TGF-P 1 levels was observed in young type 1 diabetic patients. Urinary TGF-beta 1 is associated with 2 interrelated tubular markers, alpha 1-microglobulin and urinary glucose.
引用
收藏
页码:664 / 668
页数:5
相关论文
共 29 条
[1]   Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM [J].
Berg, UB ;
Torbjörnsdotter, TB ;
Jaremko, G ;
Thalme, B .
DIABETOLOGIA, 1998, 41 (09) :1047-1056
[2]   CYTOKINES IN KIDNEY-DISEASE - THE ROLE OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BORDER, WA ;
NOBLE, NA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) :105-113
[3]   Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents [J].
Bouhanick, B ;
Gallois, Y ;
Hadjadj, S ;
de Casson, FB ;
Limal, JM ;
Marre, M .
DIABETES CARE, 1999, 22 (04) :618-622
[4]   TUBULAR DYSFUNCTION AND MICROALBUMINURIA IN INSULIN DEPENDENT DIABETES [J].
CHIARELLI, F ;
LAPENNA, G ;
MORGESE, G .
ARCHIVES OF DISEASE IN CHILDHOOD, 1989, 64 (04) :635-635
[5]   Urinary transforming growth factor-β (TGF-β) excretion and renal production of TGF-β in rats with subtotal renal ablation:: Effect of enalapril and nifedipine [J].
de Freitas, ASM ;
Coimbra, TM ;
Costa, RS ;
Baroni, EA .
NEPHRON, 1998, 78 (03) :302-309
[6]  
DiPaolo S, 1996, AM J PATHOL, V149, P2095
[7]  
Ellis D, 1998, CLIN CHEM, V44, P950
[8]  
FAGERUDD JA, 1997, KIDNEY INT S63, V52, P195
[9]   Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes -: Effects of ACE inhibition [J].
Gilbert, RE ;
Cox, A ;
Wu, LL ;
Allen, TJ ;
Hulthen, UL ;
Jerums, G ;
Cooper, ME .
DIABETES, 1998, 47 (03) :414-422
[10]   Genetic control of the circulating concentration of transforming growth factor type β1 [J].
Grainger, DJ ;
Heathcote, K ;
Chiano, M ;
Snieder, H ;
Kemp, PR ;
Metcalfe, JC ;
Carter, ND ;
Spector, TD .
HUMAN MOLECULAR GENETICS, 1999, 8 (01) :93-97